Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
Inés Ibarra‐Lecue, Paula Unzueta‐Larrinaga, R. Barrena-Barbadillo, et al.
Addiction Biology (2022) Vol. 27, Iss. 6
Open Access | Times Cited: 16

Showing 16 citing articles:

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence
Riccardo Bortoletto, Fabiana Piscitelli, Anna Candolo, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis
Albert Stuart Reece, Gary Kenneth Hulse
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 24, pp. 16721-16721
Open Access | Times Cited: 12
Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies
Lucy R. Thomsen, Rhonda J. Rosengren, Michelle Glass
Psychoactives (2024) Vol. 3, Iss. 3, pp. 365-383
Open Access | Times Cited: 2
In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution
Amy L. Cherry, Michael Wheeler, Karolina Mathisova, et al.
Frontiers in Neuroinformatics (2024) Vol. 18
Open Access | Times Cited: 2
Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
Natalia Mansur Haddad, Leonardo Peroni De Jesus, Maurício H. Serpa, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Marta Casquero‐Veiga, et al.
Psychiatry Research (2023) Vol. 331, pp. 115643-115643
Closed Access | Times Cited: 3
Differential Serum Metabolomic Profile in Patients with Schizophrenia, Cannabis Use Disorder or Dual diagnosis
Leyre Urigüen, Aitor Villate, Maitane Olivares, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Searching for biomarkers in the fluidity of mental ill‐health
Antonio Verdejo‐García
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 268-270
Open Access | Times Cited: 1
Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics
Albert Stuart Reece, Gary Kenneth Hulse
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome
Albert Stuart Reece, Gary Kenneth Hulse
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
The Endocannabinoid Activity Remodulation for psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis
Riccardo Bortoletto, Marco Garzitto, Fabiana Piscitelli, et al.
Research Square (Research Square) (2024)
Open Access
Análise do sistema endocanabinoide e ganho de peso em indivíduos com esquizofrenia em uso de clozapina
Natalia Mansur Haddad de Oliveira Santos
(2024)
Open Access
Anandamide in disease: Role in psychosis
M. Belen Blasco, Carlos A. Pretell Annan, Romina Mizrahi
Elsevier eBooks (2024), pp. 245-268
Closed Access
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Oral Supplementation for Individuals at Clinical High Risk of Psychosis
Riccardo Bortoletto, Marco Garzitto, Fabiana Piscitelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1230-1230
Open Access
Uncovering metabolic dysregulation in schizophrenia and cannabis use disorder through untargeted plasma lipidomics
Aitor Villate, Maitane Olivares, Aresatz Usobiaga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top